|
 |
|
|||||||
|
|||||||||
© 2003 by the American Diabetes Association, Inc.
Pathophysiology/Complications |
Smoking and Progression of Diabetic Nephropathy in Type 1 Diabetes
1 Steno Diabetes Center, Gentofte, Denmark
2 Faculty of Health Science, University of Aarhus, Aarhus, Denmark
OBJECTIVE—Cigarette smoking contributes to development of diabetic nephropathy. However, long-term studies on the effect of smoking on decline in kidney function in diabetic nephropathy are lacking. We assessed the impact of smoking on progression of diabetic nephropathy in type 1 diabetic patients enrolled in a prospective observational cohort study started in 1983.
RESEARCH DESIGN AND METHODS—We identified all albuminuric type 1 diabetic patients (n = 301) followed for at least 3 years, median (range) 7 years (3–14), who underwent at least yearly measurement of glomerular filtration rate (GFR) by the 51Cr-EDTA plasma clearance technique (n = 8, range 3–24). In total, 192 men and 109 women were included (age [mean ± SD] 36 ± 11 years, duration of diabetes 22 ± 8 years); 271 patients were treated with antihypertensive drugs, predominantly ACE inhibitors in 179 patients. Patients were classified as smokers if they smoked more than one cigarette per day during a portion of or the entire observation period. Blood pressure, albuminuria, HbA1c, and serum cholesterol were measured every 3–4 months during the study.
RESULTS—In all 301 patients, the mean (SE) rate of decline in GFR (
GFR) was 4.0 (0.2) ml · min-1 · year-1 during the investigation period. No difference in GFR was demonstrated between nonsmokers (n = 94), GFR 4.5 (0.4), ex-smokers (n = 31), GFR 3.1 (0.7), and smokers (n = 176), GFR 3.9 (0.3) ml · min-1 · year-1, respectively (NS). Adjustment for other risk factors for progression of diabetic nephropathy did not alter the results: smoking was not associated with GFR, whereas blood pressure, albuminuria, HbA1c, and serum cholesterol were demonstrated to be independent progression promoters.
CONCLUSIONS—In our study, smoking was not associated with decline in kidney function in type 1 diabetic patients with diabetic nephropathy.
Abbreviations: GFR, glomerular filtration rate
CiteULike 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  K. Raile, A. Galler, S. Hofer, A. Herbst, D. Dunstheimer, P. Busch, and R. W. Holl Diabetic Nephropathy in 27,805 Children, Adolescents, and Adults With Type 1 Diabetes: Effect of diabetes duration, A1C, hypertension, dyslipidemia, diabetes onset, and sex Diabetes Care, October 1, 2007; 30(10): 2523 - 2528. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Ozan, M. Sonmez, S Ozan, N Colakoglu, S Yilmaz, and T Kuloglu Effects of melatonin and vitamin C on cigarette smoke-induced damage in the kidney Toxicology and Industrial Health, September 1, 2007; 23(8): 479 - 485. [Abstract] [PDF]
|
|
|
|
 |
|
 S. R. Orth, T. Schroeder, E. Ritz, and P. Ferrari Effects of smoking on renal function in patients with type 1 and type 2 diabetes mellitus Nephrol. Dial. Transplant., November 1, 2005; 20(11): 2414 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Gross, M. J. de Azevedo, S. P. Silveiro, L. H. Canani, M. L. Caramori, and T. Zelmanovitz Diabetic Nephropathy: Diagnosis, Prevention, and Treatment Diabetes Care, January 1, 2005; 28(1): 164 - 176. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Gaede, L. Tarnow, P. Vedel, H.-H. Parving, and O. Pedersen Remission to normoalbuminuria during multifactorial treatment preserves kidney function in patients with type 2 diabetes and microalbuminuria Nephrol. Dial. Transplant., November 1, 2004; 19(11): 2784 - 2788. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Diabetes | Diabetes Care | Clinical Diabetes | Diabetes Spectrum |